Literature DB >> 9950197

Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma.

J Mora1, N Wollner.   

Abstract

BACKGROUND: Primary epidural non-Hodgkin lymphoma (NHL) is a rare but devastating event in pediatric oncology. Spinal cord compression due to an epidural mass from NHL, although it presents as a localized problem, in fact, is a systemic disease. Over the last 3 decades, aggressive systemic treatments with central nervous system prophylaxis have been designed with improving results. PROCEDURE: We reviewed the 20-year experience of the treatment of NHL with the LSA2-L2 protocol in our institution. Among 256 patients treated, five presented with primary epidural mass. Clinical features, treatment, and outcome of those five patients are presented.
RESULTS: Three patients out of five responded favorably, and after a median follow-up of 10 years, they are cured. After presenting with paraplegia, functional and neurological recoveries were excellent. Of the patients who failed treatment, relapse occurred early, either during the treatment or right after completion of therapy. The relapses were within the central nervous system as well as systemic.
CONCLUSIONS: Patients with primary epidural NHL presented with long histories of persistent back pain. Plain films of the spine were useless. All patients were diagnosed when neurologic damage had already been established. However, when the epidural NHL is treated aggressively with systemic chemotherapy and vigorous rehabilitation, the prognosis for complete neurological recovery and cure of the lymphoma is encouraging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950197     DOI: 10.1002/(sici)1096-911x(199902)32:2<102::aid-mpo6>3.0.co;2-y

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

1.  Primary spinal cord epidural non-Hodgkin's Lymphoma as cause of paraplegia: report of 2 cases.

Authors:  N Mkandawire
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

Review 2.  Imaging of back pain in children.

Authors:  D P Rodriguez; T Y Poussaint
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-19       Impact factor: 3.825

3.  Primary spinal epidural lymphomas.

Authors:  Goutham Cugati; Manish Singh; Anil Pande; Ravi Ramamurthi; Mahalakshmi Balasubramanyam; Sumer K Sethi; Ajai Kumar Singh
Journal:  J Craniovertebr Junction Spine       Date:  2011-01

4.  Primary spinal epidural diffuse large B-cell lymphoma with paraplegia as the first manifestation: a case report.

Authors:  Yefei Shu; Anlong Wang; Li Yi; Xiaofeng Xu; Wei Yang
Journal:  Onco Targets Ther       Date:  2019-08-14       Impact factor: 4.147

Review 5.  Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management.

Authors:  Salem M Bahashwan; Osman O Radhwi; Hatem M Alahwal; Abdullah T Almohammadi; Ahmed S Barefah; Yara M Daous; Fahad A Alghamdi
Journal:  Am J Case Rep       Date:  2022-06-21

6.  Primary epidural lymphocyte-depleted Hodgkin's lymphoma of the thoracic spine - presentation of a rare disease variant.

Authors:  Ekkehard M Kasper; Fred C Lam; Markus M Luedi; Pascal O Zinn; German A Pihan
Journal:  BMC Neurol       Date:  2012-08-03       Impact factor: 2.474

7.  Paravertebral Burkitt's Lymphoma in a Child: An Unusual Presentation.

Authors:  C Hoyoux; P Forget; C Piette; M F Dresse; B Florkin; L Rausin; A Thiry
Journal:  Case Rep Med       Date:  2012-11-24

8.  Early rehabilitation improves neurofunctional outcome after surgery in children with spinal tumors.

Authors:  Nezire Kose; Ozge Muezzinoglu; Sevil Bilgin; Sevilay Karahan; Ilkay Isikay; Burcak Bilginer
Journal:  Neural Regen Res       Date:  2014-01-15       Impact factor: 5.135

9.  Primary CNS Burkitt Lymphoma: A Case Report of a 55-Year-Old Cerebral Palsy Patient.

Authors:  Kathryn Bower; Nilay Shah
Journal:  Case Rep Oncol Med       Date:  2018-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.